
William A. Craigo
Examiner (ID: 17649, Phone: (571)270-1347 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 936 |
| Issued Applications | 383 |
| Pending Applications | 126 |
| Abandoned Applications | 445 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17192010
[patent_doc_number] => 11160738
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Method for forming a catalyzed dye system
[patent_app_type] => utility
[patent_app_number] => 16/365255
[patent_app_country] => US
[patent_app_date] => 2019-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 18
[patent_no_of_words] => 4935
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16365255
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/365255 | Method for forming a catalyzed dye system | Mar 25, 2019 | Issued |
Array
(
[id] => 16221203
[patent_doc_number] => 20200246319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COGNITIVE IMPAIRMENT-RELATED DISEASE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COGNITIVE IMPAIRMENT-RELATED DISEASE PREPARED BY THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/652065
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652065
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/652065 | Method for preparing pharmaceutical composition for preventing or treating cognitive impairment-related disease and pharmaceutical composition for preventing or treating cognitive impairment-related disease prepared by the same | Mar 18, 2019 | Issued |
Array
(
[id] => 18716555
[patent_doc_number] => 11793878
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Drug formulations comprising polyoxazolines as matrix excipient
[patent_app_type] => utility
[patent_app_number] => 16/980651
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 7967
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980651
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980651 | Drug formulations comprising polyoxazolines as matrix excipient | Mar 17, 2019 | Issued |
Array
(
[id] => 14501195
[patent_doc_number] => 20190194252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
[patent_app_type] => utility
[patent_app_number] => 16/298902
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298902
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/298902 | THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS | Mar 10, 2019 | Abandoned |
Array
(
[id] => 16822701
[patent_doc_number] => 20210137994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => FECAL MATTER FOR PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/976055
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976055
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/976055 | Fecal matter for treatment of autoimmune diseases | Feb 28, 2019 | Issued |
Array
(
[id] => 16805996
[patent_doc_number] => 20210128549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => OXYCODONE AND METHYLNALTREXONE MULTIPARTICULATES AND SUSPENSIONS CONTAINING THEM
[patent_app_type] => utility
[patent_app_number] => 16/976378
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -72
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976378
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/976378 | OXYCODONE AND METHYLNALTREXONE MULTIPARTICULATES AND SUSPENSIONS CONTAINING THEM | Feb 27, 2019 | Abandoned |
Array
(
[id] => 16539241
[patent_doc_number] => 20200405654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => CALCIUM SILICATE-CONTAINING ACRYLIC ADHESIVE PATCH
[patent_app_type] => utility
[patent_app_number] => 16/975876
[patent_app_country] => US
[patent_app_date] => 2019-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975876
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/975876 | CALCIUM SILICATE-CONTAINING ACRYLIC ADHESIVE PATCH | Feb 17, 2019 | Abandoned |
Array
(
[id] => 17733284
[patent_doc_number] => 20220218743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => SILVER FLUORIDE SOLUTIONS FOR DENTAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/615093
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615093
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615093 | SILVER FLUORIDE SOLUTIONS FOR DENTAL COMPOSITIONS | Feb 6, 2019 | Pending |
Array
(
[id] => 14818249
[patent_doc_number] => 10406108
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-09-10
[patent_title] => Thyroid hormone oral dosage forms and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 16/257755
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 13000
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16257755
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/257755 | Thyroid hormone oral dosage forms and methods of using the same | Jan 24, 2019 | Issued |
Array
(
[id] => 14342797
[patent_doc_number] => 20190153371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => NANOLIPIDS WITH ENCAPSULATED ALCOHOL
[patent_app_type] => utility
[patent_app_number] => 16/256661
[patent_app_country] => US
[patent_app_date] => 2019-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16256661
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/256661 | Nanolipids with encapsulated alcohol | Jan 23, 2019 | Issued |
Array
(
[id] => 17489228
[patent_doc_number] => 11278509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Lithium salts of N-substituted glycine compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/252280
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13603
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16252280
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/252280 | Lithium salts of N-substituted glycine compounds and uses thereof | Jan 17, 2019 | Issued |
Array
(
[id] => 17227083
[patent_doc_number] => 20210353639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => MAST1 AND USES FOR DIAGNOSING AND TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/963454
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963454
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/963454 | MAST1 AND USES FOR DIAGNOSING AND TREATING CANCER | Jan 17, 2019 | Abandoned |
Array
(
[id] => 14337919
[patent_doc_number] => 20190150932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => EMBOLIZATION DEVICE CONSTRUCTED FROM EXPANSILE POLYMER
[patent_app_type] => utility
[patent_app_number] => 16/250880
[patent_app_country] => US
[patent_app_date] => 2019-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16250880
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/250880 | Embolization device constructed from expansile polymer | Jan 16, 2019 | Issued |
Array
(
[id] => 14338975
[patent_doc_number] => 20190151460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 16/249415
[patent_app_country] => US
[patent_app_date] => 2019-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 299
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16249415
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/249415 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES | Jan 15, 2019 | Abandoned |
Array
(
[id] => 14306497
[patent_doc_number] => 20190142952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 16/241287
[patent_app_country] => US
[patent_app_date] => 2019-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16241287
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/241287 | Modified release formulations containing drug-ion exchange resin complexes | Jan 6, 2019 | Issued |
Array
(
[id] => 20451775
[patent_doc_number] => 12514818
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
[patent_app_type] => utility
[patent_app_number] => 16/955373
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 24196
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955373
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955373 | Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system | Dec 17, 2018 | Issued |
Array
(
[id] => 14649099
[patent_doc_number] => 20190231678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
[patent_app_type] => utility
[patent_app_number] => 16/224669
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16224669
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/224669 | Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same | Dec 17, 2018 | Abandoned |
Array
(
[id] => 14435491
[patent_doc_number] => 20190175617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => DEXAMETHASONE ORAL FILM
[patent_app_type] => utility
[patent_app_number] => 16/213617
[patent_app_country] => US
[patent_app_date] => 2018-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16213617
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/213617 | Dexamethasone oral film | Dec 6, 2018 | Issued |
Array
(
[id] => 16105393
[patent_doc_number] => 10695281
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Late stage addition of rheology modifier
[patent_app_type] => utility
[patent_app_number] => 16/204725
[patent_app_country] => US
[patent_app_date] => 2018-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 10679
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16204725
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/204725 | Late stage addition of rheology modifier | Nov 28, 2018 | Issued |
Array
(
[id] => 16961433
[patent_doc_number] => 20210212932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => METHODS AND COMPOSITIONS FOR INHIBITING A NOXIOUS INSULT
[patent_app_type] => utility
[patent_app_number] => 17/058441
[patent_app_country] => US
[patent_app_date] => 2018-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058441
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058441 | METHODS AND COMPOSITIONS FOR INHIBITING A NOXIOUS INSULT | Nov 15, 2018 | Abandoned |